These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6896607)

  • 1. [Successful treatment of malignant hyperthermia with dantrolene-sodium and uneventful re-anaesthesia after oral dantrolene-prophylaxis (author's transl)].
    Schulte-Sasse U; Tarnow J; Eberlein HJ
    Anaesthesist; 1982 May; 31(5):241-4. PubMed ID: 6896607
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
    Friesen CM; Brodsky JB; Dillingham MF
    Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the treatment of malignant hyperthermia. A simple method of preparing a dantrolene sodium solution (author's transl)].
    Drechsler H
    Anaesthesist; 1981 May; 30(5):257-8. PubMed ID: 7247013
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
    Blank JW; Boggs SD
    J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl)].
    Schuh FT; Maier C
    Anaesthesist; 1982 May; 31(5):245-7. PubMed ID: 7103032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of malignant hyperthermia?
    Broekema AA; Boersma GA; Hennis PJ
    Anaesthesia; 1991 Nov; 46(11):942-5. PubMed ID: 1750596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant hyperthermia. II. Investigation of the patient's family (author's transl)].
    Plötz J
    Anaesthesist; 1980 Feb; 29(2):94-8. PubMed ID: 7377529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
    Bernhardt D
    Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case.
    Wuis EW; Driessen JJ; Evers J; Vree TB; van der Kleyn E
    Eur J Anaesthesiol; 1986 May; 3(3):219-23. PubMed ID: 3780690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
    de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
    Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
    Harrison GG
    Br J Anaesth; 1975 Jan; 47(1):62-5. PubMed ID: 1148076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
    Harrison GG
    S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant hyperthermia. Current aspects of dantrolene treatment of 2 cases of hyperthermia maligna incipiens].
    Hoffmann-Lundgren B; Kühn K; Hausdörfer J
    Anasth Intensivther Notfallmed; 1982 Jun; 17(3):169-70. PubMed ID: 7125160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium].
    Noda B; Higa K; Naitoh H; Dan K
    Masui; 1985 Jun; 34(6):822-7. PubMed ID: 4032707
    [No Abstract]   [Full Text] [Related]  

  • 15. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant hyperthermia].
    Grote B
    Anaesthesist; 1980 Feb; 29(2):53-4. PubMed ID: 7377524
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful Treatment Without Using Dantrolene Sodium on a Child Occurring Malignant Hyperthermia During Induction of General Anesthesia: A Case Report.
    Zheng Q; Liu N; Zeng Y; Chen Y; Zhang H; Su X; Zhuang J
    J Craniofac Surg; 2024 Jun; 35(4):e351-e354. PubMed ID: 38829149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative hyperthermia of unknown origin treated with dantrolene sodium.
    Inada H; Jinno S; Kohase H; Fukayama H; Umino M
    Anesth Prog; 2005; 52(1):21-3. PubMed ID: 15859445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.